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Background
Recombinant adenovirus (rAd) vectors elicit robust adap-
tive immunity, presumably as a result of efficient trigger-
ing of innate immune pathways. Here, we examined the
contribution of Toll-like receptor (TLR) signaling to shap-
ing antigen-specific CD8+ T-cell responses generated by
rAd vectors in mice.
Methods
C57BL/6 (WT), MyD88-/-, TRIF-/- and TLR9-/- mice were
immunized with a single i.m. injection of rAd5,
rAd5HVR48, rAd26 or rAd35 expressing SIV-Gag. Follow-
ing immunization, Gag-specific cellular immune
responses were assessed by Db/AL11 tetramer binding
assays and IFN-gamma ELISPOT responses.
Results
MyD88-/- mice immunized with 3 × 108 vp of each respec-
tive rAd vector generated significantly diminished
tetramer-positive CD8+T-cell responses as compared with
WT mice. By day 28 post-immunization, rAd5-Gag pro-
duced mean tetramer-positive responses of 3.5% in
MyD88-/- mice as compared with 12.6% in WT mice (p =
.0004). Similarly, tetramer-positive responses elicited by
rAd5HVR48-Gag (4.4% vs 9.0%), rAd26-Gag (0.3% vs
6.3%) and rAd35-Gag (3.7% vs 6.6%) were also signifi-
cantly diminished in MyD88-/- mice as compared with
WT mice. These results were confirmed by functional IFN-
gamma ELISPOT assays. However, dependence on
MyD88 was overcome when rAd vectors were given at
higher doses. In contrast, TRIF-/- mice immunized with 3
× 108 vp of rAd vectors mounted comparable or higher
tetramer-positive responses as compared with WT mice.
TLR9-/- mice immunized with these rAd vectors displayed
no difference in antigen-specific CD8+ T-cell responses
when compared to WT mice.
Conclusion
These data show that antigen-specific CD8+ T-cell
responses elicited by rAd vectors are diminished in the
absence of MyD88 signaling. The absence of TRIF did not
impair the immunogenicity of rAd vectors. The partial
dependence on MyD88 could be overcome by increasing
vector dose, suggesting that both MyD88-dependent and
-independent pathways contribute to adaptive immune
responses elicited by rAd vectors.
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